Antitumor effect of interferon-on U937 human acute leukemia cells in vitro and its molecular mechanism

Abstract

In order to investigate the antitumor effect and molecular mechanism of interferon-α (IFN-α) on human acute myeloid leukemia cell line U937 cells in vitro, the proliferation of U937 cells was determined by MTT assay, the apoptosis rate was analyzed by flow cytometry (FCM), and the mRNA expression of cell cycle regulatory protein cyclin E was detected by RT-PCR. The results showed that IFN-α could inhibit the proliferation of U937 cells significantly in a dose-and time-dependent way (P<0.01), and induce the apoptosis of U937 cells also in a dose-and time-dependent manner at the concentration of 1000 4000 U/L (P<0.01). The apoptosis rate of U937 cells was even over 50% when cultured with IFN-for 36 48 h at the concentration of 2000 4000 U/L. Moreover, the expression of cyclin E mRNA was markedly inhibited by the addition of IFN-, and the inhibition was time-dependent (P<0.01). It was concluded that the anti-leukemia mechanism of IFN-α might be correlated with its antiproliferative and apoptotic inducing effects, and the down-regulation of the cyclin E expression might be one of its molecular mechanisms.

Keywords

interferon-α / acute leukemia / cyclin E / apoptosis

References

[1] LeclereS., MyersR. P., MousalliJ., et al.. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med, 2003, 14(4): 237-243

[2] LiedtkeC., GrogerN., MannsM. P., et al.. Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells. J Hepatol, 2006, 44(2): 342-349

[3] TaylorK. L., OatesR. K., GraneR., et al.. IFN-alphal, 8 inhibits tumor-induced angiogenesis in murine angiosarcomas. J Interferon Cytokine Res, 2006, 26(5): 353-361

[4] LehtonenA., LundR., LahesmaaR., et al.. IFN-alpha and IL-12 activate IFN regulatory factor 1 (IRF-1), IRF-4, and IRF-8 gene expression in human NK and T cells. Cytokine, 2003, 24(3): 81-90

[5] KellyJ. D., DaiJ., EschwegeP., et al.. Down-regulation of Bel-2 sensitizes interferon-resistant renal cancer cells to Fas. Br J Cancer, 2004, 91(1): 164-170

[6] AleemE., KiyokawaH., KaldisP., et al.. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol, 2005, 7(8): 831-836

[7] LundbergA. S., WeibergR.A.. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol, 1998, 18(11): 753-762

[8] RosenD. G., YangG., DeaversM. T., et al.. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma. Cancer, 2006, 106(9): 1925-1932

[9] LidaH., TowaltariM., TanmotoM., et al.. Overexpression of cyclin E in acute myelogenous leukemia. Blood, 1997, 11(9): 3707-3713